News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
GRAF FINCKENSTEIN FRIEDRICH
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 07/17/2023 |
4
| GRAF FINCKENSTEIN FRIEDRICH (Chief Medical Officer) has filed a Form 4 on IOVANCE BIOTHERAPEUTICS, INC.|
Txns:
| Paid exercise price by delivering 1,395 shares
@ $7.76, valued at
$10.8k
Exercised 2,813 restricted stock units
@ $0 |
|
| 04/18/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/06/2023 |
4
| GRAF FINCKENSTEIN FRIEDRICH (Chief Medical Officer) has filed a Form 4 on IOVANCE BIOTHERAPEUTICS, INC.|
Txns:
| Granted 46,875 restricted stock units
@ $0
Granted 93,750 options to buy
@ $7.12, valued at
$667.5k
|
|
| 01/19/2023 |
4
| GRAF FINCKENSTEIN FRIEDRICH (Chief Medical Officer) has filed a Form 4 on IOVANCE BIOTHERAPEUTICS, INC.|
Txns:
| Paid exercise price by delivering 4,678 shares
@ $6.43, valued at
$30.1k
Exercised 11,248 restricted stock units
@ $0 |
|
| 01/05/2023 |
4
| GRAF FINCKENSTEIN FRIEDRICH (Chief Medical Officer) has filed a Form 4 on IOVANCE BIOTHERAPEUTICS, INC.|
Txns:
| Paid exercise price by delivering 11,023 shares
@ $6.11, valued at
$67.4k
Exercised 19,690 restricted stock units
@ $0 |
|
| 06/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/19/2022 |
4
| GRAF FINCKENSTEIN FRIEDRICH (Chief Medical Officer) has filed a Form 4 on IOVANCE BIOTHERAPEUTICS, INC.|
Txns:
| Granted 33,750 restricted stock units
@ $0
Granted 67,500 options to buy
@ $15.49, valued at
$1M
|
|
| 06/16/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/06/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/07/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/19/2019 |
4
| GRAF FINCKENSTEIN FRIEDRICH (Chief Medical Officer) has filed a Form 4 on IOVANCE BIOTHERAPEUTICS, INC.|
Txns:
| Granted 160,000 options to buy
@ $25.78, valued at
$4.1M
|
|
| 07/19/2019 |
3
| GRAF FINCKENSTEIN FRIEDRICH (Chief Medical Officer) has filed a Form 3 on IOVANCE BIOTHERAPEUTICS, INC. |
|
|